Below you will find our consolidated key figures and our financial calendar, or you can go directly to our financial reports and SEC filings

Key Financials

Consolidated Key Figures

(thousands of €, if not stated otherwise)Year ended 31 December 2023Year ended 31 December 2022
Income statement
Collaboration revenues239,724241,249
R&D expenditure(241,294)(269,797)
S&M, G&A expenses(133,965)(138,635)
Other operating income47,27236,127
Operating loss(88,263)(131,056)
Net financial results93,88860,207
Net loss from continuing operations(3,988)(71,421)
Net profit/loss (-) from discontinued operations, net of tax215,685(146,570)
Net profit/loss (-)211,697(217,991)
Income statement from discontinued operations
Product net sales112,33987,599
Collaboration revenues431,465176,432
Cost of sales(18,022)(12,079)
R&D expenditure(190,177)(245,286)
S&M, G&A expenses(131,346)(153,851)
Other operating income13,00310,721
Operating profit/loss (-)217,262(136,464)
Net financial results499(7,834)
Net profit/loss (-) from discontinued operations, net of tax215,685(146,570)
Balance sheet
Cash and cash equivalents166,803508,117
Current financial investments3,517,6983,585,945
R&D incentives receivables178,688146,067
Shareholders’ equity2,795,5662,526,026
Deferred income1,327,4631,989,230
Other liabilities234,367219,094
Cash flow
Operational cash burn (*)(414,824)(513,774)
Cash flow used in operating activities(405,970)(500,544)
Cash flow generated from/used in (-) investing activities71,186(1,245,514)
Cash flow used in financing activities(5,001)(1,487)
Decrease in cash and cash equivalents(339,785)(1,747,545)
Effect of currency exchange rate fluctuation on cash and cash equivalents(1,522)22,293
Cash and cash equivalents on 31 December166,810508,117
Cash and cash equivalents from continuing operations166,803508,117
Cash and cash equivalents included in assets classified as held for sale7
Current financial investments on 31 December3,517,6983,585,945
Total current financial investments and cash and cash equivalents on 31 December3,684,5144,094,062
Financial ratios
Number of shares issued on 31 December65,897,07165,835,511
Basic and diluted income/loss (-) per share (in €)3.21(3.32)
Share price on 31 December (in €)36.9941.35
Total group employees on 31 December (number)(**)1,1231,338

(*)The operational cash burn (or operational cash flow if this liquidity measure is positive) is equal to the increase or decrease in our cash and cash equivalents (excluding the effect of exchange rate differences on cash and cash equivalents), minus:

  • (the net proceeds, if any, from share capital and share premium increases included in the net cash flows generated from/used in (-) financing activities
  • (the net proceeds or cash used, if any, related to the acquisitions or disposals of businesses; the acquisition of financial assets held at fair value through profit or loss; the movement in restricted cash and movement in current financial investments, if any, the cash advances and loans given to third parties, if any, included in the net cash flows generated from/used in (-) investing activities
  • (the cash used for other liabilities related to the acquisition of businesses, if any, included in the net cash flows generated from/used in (-) operating activities.

(**) Including in 2023 all employees transferred to Alfasigma on 1 February 2024 following the successful completion of the transfer of the Jyseleca® business

Financial Reports & Accounts

Annual Report? H1 Report? In-depth financial reports, right here!

Financial Calendar

Full year 2023 results22 February 2024Webcast 23 February 2024
Annual Report 202328 March 2024 
Annual shareholders’ meeting30 April 2024 
First quarter 2024 results2 May 2024Webcast 3 May 2024
Half-year 2024 results1 August 2024Webcast 2 August 2024
Third quarter 2024 results30 October 2024Webcast 31 October 2024

SEC Filings

SEC filings are the official documents we submit to the U.S. Securities and Exchange Commission (SEC). They contain financial and non-financial information essential for regulatory compliance and transparency.